Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

CZECANCA Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium, HEBON Investigators, gemo study collaborators, AOCS Group

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology